Status:

UNKNOWN

Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection

Lead Sponsor:

University Hospital, Rouen

Conditions:

Corona Virus Infection

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The SARS-CoV-2 (COVID-19) infection is causing a global pandemic and a major health crisis in France. Immunity is the body's ability to defend itself against infectious agents such as viruses. The pr...

Eligibility Criteria

Inclusion

  • Patient with an acute SARS-CoV-2 infection, confirmed by PCR or typical CT images, requiring hospitalization in a COVID unit at the Rouen University Hospital (pneumonic form requiring oxygen therapy \< 4 L/min.)
  • Rouen University Hospital staff free of any symptomatology compatible with an SARS-CoV-2 infection (fever, cough, fatigue, loss of taste, loss of smell) since February 1, 2020
  • Age ≥ 18 years old
  • Adult patient who has read and understood the information letter and signed the consent form
  • Affiliation to a social security scheme

Exclusion

  • Patient with PCR-confirmed SARS-CoV-2 infection and hospitalized in intensive care units (acute respiratory distress and/or organ failure, whose pathogenesis may differ from the more frequently described forms with secondary aggravation (5)).
  • Patient with PCR-confirmed but non-hospitalized SARS-CoV-2 infection (non-acute form, managed by confinement)
  • A person participating in a therapeutic trial that may interfere with the procedures being investigated, including lymphocyte response prior to D+56±14 days.
  • Known Pregnancy
  • Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / subtutorship or guardianship
  • Staff at the Rouen University Hospital with SARS-CoV-2 infection confirmed by PCR and/or typical scan images during the epidemic period.
  • Hospital staff who were exposed to the virus (working in a Covid unit)

Key Trial Info

Start Date :

April 16 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 10 2021

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04707820

Start Date

April 16 2020

End Date

June 10 2021

Last Update

January 13 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rouen University Hospital

Rouen, France

Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection | DecenTrialz